{
  "@context": {
    "dcterms": "http://purl.org/dc/terms/",
    "cito": "http://purl.org/spar/cito/",
    "deo": "http://purl.org/spar/deo/"
  },
  "@id": "https://hypothesis.bioagent.ai/gzsmhpl7e9t",
  "@type": "deo:FutureWork",
  "cito:usesDataFrom": [
    "https://doi.org/10.1186/s13041-024-01028-8",
    "https://doi.org/10.1234/62408",
    "https://doi.org/10.18632/aging.205322",
    "https://doi.org/10.3390/ph17030270",
    "https://doi.org/10.1007/s00401-023-02574-0",
    "https://doi.org/10.1186/s13195-022-01128-y"
  ],
  "dcterms:references": [
    "# Connecting DOPAL's Anti-Aβ Oligomerization Effects with Neprilysin Activity: A Mechanistic Hypothesis\n\n## 1. Background\nDOPAL (3,4-dihydroxyphenylacetaldehyde), a reactive aldehyde metabolite of dopamine, has been found to decrease amyloid-beta (Aβ) oligomerization in human neuroblastoma cells, thereby reducing Aβ cytotoxicity. Neprilysin (NEP) serves as one of the primary Aβ-degrading enzymes in the brain, particularly targeting monomeric Aβ species, and its expression decreases with age and in Alzheimer's disease (AD). L-DOPA treatment, as demonstrated in Abstract 1, significantly reduces Aβ plaque burden in 5xFAD mice by upregulating NEP levels, suggesting dopamine pathway involvement in amyloid clearance mechanisms. The glymphatic system, referenced in Abstract 5, plays a crucial role in maintaining the balance between production and clearance of Aβ, with impairments observed in AD patients.\n\n## 2. Knowledge Gap\nWhile both DOPAL's anti-oligomerization effects and neprilysin's degradative activity influence Aβ accumulation, the potential mechanistic interplay between these processes remains unexplored. Specifically, it is unknown whether DOPAL's ability to prevent Aβ oligomerization and neprilysin's capacity to degrade Aβ monomers operate independently or function in a coordinated manner that enhances overall Aβ clearance efficiency.\n\n## 3. Central Hypothesis\nDOPAL enhances neprilysin-mediated Aβ clearance through a dual-action mechanism: directly maintaining Aβ in its monomeric form through covalent adduction at oligomerization-critical residues while simultaneously activating a DJ-1-dependent redox pathway that upregulates neprilysin expression and activity.\n\n## 4. Proposed Mechanism\n1. DOPAL, through its reactive aldehyde group, forms Schiff base adducts with lysine residues in the Aβ peptide (particularly Lys16 and Lys28) that are critical for β-sheet formation and oligomerization, thereby stabilizing Aβ in its monomeric conformation.\n\n2. This DOPAL-mediated conformational stabilization of Aβ monomers creates an optimal substrate pool for neprilysin, which preferentially cleaves monomeric rather than oligomeric Aβ forms.\n\n3. Concurrently, DOPAL engages with cellular redox sensor DJ-1 (PARK7), inducing a moderate oxidative stress response that activates the Nrf2 transcription factor pathway in neurons and astrocytes.\n\n4. Activated Nrf2 translocates to the nucleus and binds to antioxidant response elements (AREs) in the neprilysin gene promoter, increasing its transcription and protein expression in a manner similar to how L-DOPA upregulates NEP in 5xFAD mice (Abstract 1).\n\n5. This creates a feed-forward mechanism where DOPAL both increases the availability of neprilysin's preferred substrate (Aβ monomers) and enhances the enzyme's expression, resulting in accelerated Aβ degradation and reduced neurotoxicity.\n\n## 5. Testable Predictions\n1. Neurons and astrocytes treated with physiologically relevant concentrations of DOPAL should show increased neprilysin expression and activity compared to controls, and this effect should be abolished in DJ-1 knockout cells or in the presence of Nrf2 inhibitors.\n\n2. Mass spectrometry analysis of Aβ exposed to DOPAL should reveal specific DOPAL-Aβ adducts at lysine residues, and these modified Aβ species should show reduced aggregation propensity but maintained susceptibility to neprilysin degradation.\n\n3. In transgenic AD mouse models, genetic or pharmacological enhancement of endogenous DOPAL levels (through modulation of MAO activity) should increase neprilysin expression and decrease Aβ plaque burden in a manner dependent on functional DJ-1/Nrf2 signaling.\n\n## 6. Potential Experimental Approaches\n1. Develop an in vitro system using human iPSC-derived neurons co-cultured with astrocytes expressing fluorescent reporter constructs for neprilysin promoter activity. Treat these cultures with varying concentrations of DOPAL with and without DJ-1/Nrf2 pathway inhibitors, then measure neprilysin expression, Aβ degradation rates, and Aβ oligomerization using biochemical and microscopy techniques.\n\n2. Generate conditional transgenic mice with enhanced DOPAL production (by modulating key enzymes in dopamine metabolism) crossed with 5xFAD mice. Assess neprilysin levels, Aβ plaque load, and cognitive performance across different age points, with additional cohorts lacking functional DJ-1 or Nrf2 to validate the proposed signaling pathway.\n\nThis hypothesis provides a novel mechanistic framework connecting dopamine metabolism to Aβ clearance through both direct chemical interactions with Aβ and modulation of degradative pathways, potentially explaining how dopaminergic system dysfunction contributes to AD pathogenesis while suggesting new therapeutic targets that could enhance both aspects of this clearance mechanism."
  ],
  "dcterms:subject": [
    "amyloid clearance",
    "neurodegenerative diseases"
  ],
  "dcterms:source": [
    "DOPAL, a dopamine metabolite, decreases Aβ oligomerization in human neuroblastoma cells, reducing the cytotoxic effects of Aβ.",
    "The study shows that neprilysin acts as an Aβ-degrading enzyme, particularly affecting monomeric Aβ"
  ],
  "dcterms:abstract": [
    "Dopamine plays important roles in cognitive function and inflammation and therefore is involved in the pathogenesis of neurodegenerative diseases, including Alzheimer's disease (AD). Drugs that increase or maintain dopamine levels in the brain could be a therapeutic strategy for AD. However, the effects of dopamine and its precursor levodopa (L‑DOPA) on Aβ/tau pathology in vivo and the underlying molecular mechanisms have not been studied in detail. Here, we investigated whether L‑DOPA treatment alters neuroinflammation, Aβ pathology, and tau phosphorylation in 5xFAD mice, a model of AD. We found that L‑DOPA administration significantly reduced microgliosis and astrogliosis in 5xFAD mice. In addition, L‑DOPA treatment significantly decreased Aβ plaque number by upregulating NEP and ADAM17 levels in 5xFAD mice. However, L‑DOPA‑treated 5xFAD mice did not exhibit changes in tau hyperphos‑phorylation or tau kinase levels. These data suggest that L‑DOPA alleviates neuroinflammatory responses and Aβ pathology but not tau pathology in this mouse model of AD.",
    "Our current understanding of the spread and neurodegenerative effects of tau neurofibrillary tangles (NFTs) within the medial temporal lobe (MTL) during the early stages of Alzheimer’s Disease (AD) is limited by the presence of confounding non-AD pathologies and the two-dimensional (2-D) nature of conventional histology studies. Here, we combine ex vivo MRI and serial histological imaging from 25 human MTL specimens to present a detailed, 3-D characterization of quantitative NFT burden measures.",
    "The direct access of olfactory afferents to memory-related cortical systems has inspired theories about the role of the olfactory pathways in the development of cortical neurodegeneration in Alzheimer’s disease (AD). This study used longitudinal PET imaging and diffusion MRI to investigate the spatiotemporal spreading and genetic vulnerabilities of AD-related pathology aggregates in the olfactory system. We find that odor identification deficits are associated with tau accumulation in key areas of the olfactory pathway, with strong predictive power for tau progression.",
    "Aging is a process accompanied by functional decline in tissues and organs with great social and medical consequences. Developing effective anti-aging strategies is of great significance. In this study, we demonstrated that transplantation of young hematopoietic stem cells (HSCs) into old mice can mitigate aging phenotypes, underscoring the crucial role of HSCs in the aging process.",
    "Accumulating senescent cells within tissues contribute to the progression of aging and age-related diseases. Botanical extracts, rich in phytoconstituents, present a useful resource for discovering therapies that could target senescence and thus improve healthspan. Here, we show that daily oral administration of a standardized extract of Salvia haenkei (Haenkenium) extended lifespan and healthspan of naturally aged mice. HK treatment inhibited age-induced inflammation, fibrosis and senescence markers across several tissues, as well as increased muscle strength and fur thickness compared with age-matched controls.",
    "Alzheimer’s disease (AD) is one of the world’s well-known neurodegenerative diseases, which is related to the balance mechanism of production and clearance of two proteins (amyloid-β and tau) regulated by the glymphatic system. Latest studies have found that AD patients exhibit impairments to their glymphatic system. However, the alterations in the AD disease continuum, especially in the early stages, remain unclear. Moreover, the relationship between the glymphatic system and cognitive dysfunction is still worth exploring.",
    "This study investigates the relationship between nuclear genetic variants and mitochondrial DNA (mtDNA) copy number and heteroplasmy in humans. Our analysis of whole-genome sequencing data across large cohorts reveals significant nuclear control over mtDNA traits, uncovering new insights into the genetic architecture that impacts mitochondrial dynamics and their implications for human health.",
    "Using single-cell whole-genome sequencing, we identified and characterized the landscape of somatic single-nucleotide variants (sSNVs) in single cardiomyocytes from individuals across the human lifespan. Aged cardiomyocytes were found to have a higher burden of sSNVs and show mutational signatures that suggest failed repair of oxidative DNA damage.",
    "Systemic amyloidosis is a progressive disorder characterized by the extracellular deposition of amyloid fibrils and accessory proteins in visceral organs and tissues. This study describes a prototypic pan-amyloid binding peptide-antibody fusion molecule that enhances macrophage uptake of amyloid.",
    "The transfer of mitochondrial DNA into the nuclear genomes of eukaryotes (Numts) has been linked to lifespan in nonhuman species and recently demonstrated to occur in rare instances from one human generation to the next. Here, we investigated numtogenesis dynamics in humans in 2 ways. First, we quantified Numts in 1,187 postmortem brain and blood samples from different individuals.",
    "Recently proposed biomarker-only diagnostic frameworks propose that amyloid-beta is necessary for placement on the Alzheimer’s disease continuum, whereas tau in the absence of amyloid-beta is considered to be a non-Alzheimer’s disease pathologic change. Similarly, the pathologic designation of tau in the absence of amyloid-beta is characterized as primary age-related tauopathy and separable from Alzheimer’s disease.",
    "Inclusion body myositis (IBM) is the most prevalent muscle disease in adults for which no current treatment exists. The pathogenesis remains poorly defined. This study explores the interplay between inflammation and mitochondrial dysfunction in IBM, demonstrating that the NLRP3 inflammasome is activated in muscle samples from IBM patients, alongside altered mitophagy. Findings suggest a vicious cycle driving muscle weakness in IBM.",
    "Age-related macular degeneration (AMD) is the leading cause of blindness among elderly people worldwide. However, there are currently no effective treatments for AMD. In this study, a polyethylene glycol (PEG)-coated rhodium nanozyme (PEG-RhZ) with excellent reactive oxygen species (ROS) and reactive nitrogen species (RNS) elimination capability was synthesized for the treatment of AMD.",
    "Cerebrospinal fluid (CSF) is responsible for maintaining brain homeostasis through nutrient delivery and waste removal for the central nervous system (CNS). Here, we demonstrate extensive CSF flow throughout the peripheral nervous system (PNS) by tracing distribution of multimodal 1.9-nanometer gold nanoparticles, roughly the size of CSF circulating proteins, infused within the lateral cerebral ventricle (a primary site of CSF production). CSF plays a consistent role in maintaining homeostasis throughout the nervous system with implications for CNS and PNS therapy and neural drug delivery.",
    "Pathological changes in the brain begin accumulating decades before the appearance of cognitive symptoms in Alzheimer’s disease. The deposition of amyloid beta proteins and other neurotoxic changes occur, leading to disruption in functional connections between brain networks. Discrete characterization of the changes that take place in preclinical Alzheimer’s disease has the potential to help treatment development by targeting the neuropathological mechanisms to prevent cognitive decline and dementia from occurring entirely.",
    "This trial evaluates the safety and efficacy of intra-articular injection of allogeneic adipose-derived mesenchymal stromal cells (AD-MSCs) for cartilage regeneration in patients with knee osteoarthritis (KOA) over 12 months, demonstrating significant clinical improvements and MRI findings.",
    "Aging affects iron homeostasis, as evidenced by tissue iron loading and anemia in the elderly. Iron needs in mammals are met primarily by iron recycling from senescent red blood cells (RBCs), chiefly accomplished by splenic red pulp macrophages (RPMs). Here, we found that 10-11-month-old female mice exhibit iron loading in RPMs, largely due to a drop in iron exporter ferroportin, which diminishes their erythrophagocytosis capacity and lysosomal activity. We further found that feeding mice an iron-reduced diet alleviates iron accumulation in RPMs and improves their function, thus demonstrating that dietary iron reduction can rejuvenate RPMs and enhance iron turnover efficacy.",
    "Glymphatic clearance dysfunction may play an important role in a variety of neurodegenerative diseases and the progression of ageing. However, in vivo imaging of the glymphatic system is challenging. In this study, we describe an MRI method based on chemical exchange saturation transfer (CEST) of the Angiopep-2 probe to visualize the clearance function of the glymphatic system.",
    "The bottleneck in drug discovery for central nervous system diseases is the absence of effective systemic drug delivery technology for delivering therapeutic drugs into the brain. Despite advances in the technology used in drug discovery, the development of drugs for central nervous system diseases remains challenging. Here we describe the development of a novel brain-targeted drug delivery system that involves genetically engineered exosomes capable of high expression gene delivery in mice.",
    "Tau neurofibrillary tangles are a hallmark of Alzheimer’s disease neuropathological change. However, it remains largely unclear how distinctive Alzheimer’s disease tau seeds (i.e. 3R/4R) correlate with histological indicators of tau accumulation. Here, we use tau real-time quaking-induced conversion (RT-QuIC) assays to selectively quantitate 3R/4R tau seeds in the frontal lobe which accumulates histologically identifiable tau pathology at late disease stages of AD neuropathologic change.",
    "Granulovacuolar degeneration bodies (GVBs) are intracellular vesicular structures that commonly accompany pathological tau accumulations in neurons of patients with tauopathies. In this study, we show that GVBs are independently induced by tau and α-synuclein pathology, providing insights into their formation and implications in neurodegenerative diseases."
  ]
}